Longevity Acquisition Corporation focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. The company is based in Shanghai, the People's Republic of China.
On 10/22/2020 the company announced a pending merger with 4D pharma, a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs.
$13.40 +0.70 (5.51%)
As of 02/24/2021 16:00:00 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.